RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..7 of 7 - per page
Order by
Nanoparticles that exhibit high epithelial uptake and transepithelial transport More
Methods and formulations for treating or preventing Vascular Cognitive Impairment (VCI) through mucosal administration of E-selectin, an inducible adhesion molecule on endothelial cells More
Biomimic prenatal and postnatal maternal-to-infant transfer of clinical monosaccharides for improved neurologic development and immunologic functions More
Cancer immunotherapy using dendritic cells, and iii) Camel recombinant antibodies for FoxP3, Mucl & CEA. More
NexACT(R) utilizes highly effective, novel excipients or “penetration enhancers” to dramatically improve absorption and bioavailability of drugs. Varying the concentration of the enhancer allows for local or systemic delivery of drug, as desired. More
immuno-suppresant agent More
Displaying 1..7 of 7 - per page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us